Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BNVI, ORBC, VITA, CRWE - Stock Reports! from

Stock-PR Reporting



FREE Daily Stock Alerts From




Bionovo, Inc. (Nasdaq:BNVI) announced this month the publication of a study entitled "CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation" in the journal Cell Cycle. The study describes the critical linkage between the expression of the protein CC3/TIP30 in cancer cells and their ability to adapt and survive in adverse conditions such as lack of glucose and other nutrients. Lack of CC3/TIP30 in a variety of human tumors allows them to resist the death signals created by metabolic stress encountered during aggressive tumor growth and metastases. Absence of CC3/TIP30 thus contributes to the development of aggressive and metastatic cancers.

Bionovo, Inc., a clinical stage drug discovery and development company, focuses on women’s health and cancer primarily in the United States. Its lead drug candidate, Menerba, which completed a Phase II clinical trial, is a receptor sub-type selective estrogen receptor modulator for the treatment of vasomotor symptoms of menopause.


  Crown Equity Holdings Inc. (OTCPK:CRWE)

Crown Equity Holdings Inc. announced this month that its subsidiary company, Crown Tele Services Inc. ( is still moving forward after dissolving its joint venture with Communication Expert Corporation and will gradually start rolling out its internet based voice and video service IP-PBX solutions next year.

The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communication solutions specifically designed to meet the market needs.

Commenting on the venture, Kenneth Bosket, president said, "We are still excited with this opportunity to expand our footprint in this valuable market. The demand for internet-based voice and video services is growing exponentially and our new subsidiary Crown Tele Services Inc. has launched its new website and intends to emerge as a service provider of choice."

According to ABI Research, the latest global business VoIP services forecasts show that the value of the overall market, which includes VoIP integrated access, SIP trunking, hosted IP-PBX/IP Centrex and managed IP-PBX services, is set to double over the next five years, to exceed $20 billion by 2015.

CRWE announced in June of this year its 1- 10 forward stock split, as well as in August announcing that CRWE had surpassed One Million dollars (1,000,000) in sales.

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing and Web sites, which bring together targeted audiences and advertisers that want to reach them. CRWE's mission is to profitably disseminate a variety of information as a worldwide online media publisher in an environment that has a positive effect.

To learn more about CRWE visit:


ORBCOMM, Inc. (Nasdaq:ORBC) announced that Camgian Microsystems Corporation (Camgian) has selected ORBCOMM to provide a global communications platform for Quantum, its industrial asset monitoring solution. Quantum is a wireless industrial operations intelligence platform that supports the seamless integration of local area sensor networks, satellite communications and back-office analytics software for monitoring remote fixed and mobile assets.

ORBCOMM Inc., a satellite-based data communication company, operates a two-way wireless data messaging system optimized for narrowband data communications in the United States and internationally. Its system consists of a network of 29 low-Earth orbit satellites, and accompanying ground infrastructure.


Orthovita Inc. (Nasdaq:VITA) recently announced that it will present at the J.P. Morgan 29th Annual Healthcare Conference in San Francisco. Antony Koblish, President and Chief Executive Officer of Orthovita, is scheduled to present on Thursday, January 13, 2011, at 7:30 a.m. Pacific Time, at the Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102.

Orthovita, Inc., a specialty spine and orthopedic company, develops and markets orthobiologic and biosurgery products. The company’s orthobiologics platform offers products for the fusion, regeneration, and fixation of human bone; and the biosurgery platform provides products for controlling intra-operative bleeding/hemostasis.




Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At



The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.